Planep纳入医保了没？

In 2002, Planep (alias: eplerenone, Inspra) was first launched in the United States. It is mainly used clinically to treat hypertension. In 2003, the FDA approved Planep for the treatment of heart failure after acute myocardial infarction.

In 2002, it was approved for clinical use by the State Food and Drug Administration. Planep has a stronger aldosterone antagonism than spironolactone, and has extremely low affinity for androgen and progesterone receptors. It has few adverse reactions and has definite efficacy in the treatment of hypertension, heart failure and myocardial infarction. It has fewer adverse reactions and good tolerance. It is a good alternative to spironolactone. Has Planep been included in medical insurance?

It is understood that Planep has been approved for clinical use, but has not been officially launched in the country! 

What I need to tell you here is that Planep 50mg × 100 tablets from India's Lupine Pharmaceuticals costs about $500. Since exchange rates fluctuate and prices are not fixed, please consult Medical Travel for specific prices.

In addition, hypertension refers to an increase in systemic arterial blood pressure (systolic blood pressure and/or diastolic blood pressure) as the main feature (systolic blood pressure ≥ 140 mm Hg mm Hg, diastolic blood pressure ≥ 90 mm Hg mm Hg). Clinically, it may be accompanied by functional or organic damage to the heart, brain, kidney and other organs. About 60% of patients with hypertension have a family history.

It is currently believed to be caused by polygenic inheritance, and 30% to 50% of patients with hypertension have a genetic background.

Planep is a new generation of selective aldosterone antagonist. Planep can be used alone or in combination with other antihypertensive drugs for the treatment of hypertension. It also has a good antihypertensive effect on simple systolic hypertension and has a good antihypertensive effect on diet-induced obesity-related hypertension.

In addition, Planep can significantly reduce the ultrafiltration effect of glomeruli and reduce albuminuria in patients with hypertension. This renal protective effect is more obvious for hypertensive patients with diabetes.